Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy: relation to remodeling

A Rudolph, H Abdel-Aty, S Bohl, P Boyé… - Journal of the American …, 2009 - jacc.org
Objectives: We aimed to evaluate the incidence and patterns of late gadolinium
enhancement (LGE) in different forms of left ventricular hypertrophy (LVH) and to determine …

Interstitial fibrosis, left ventricular remodeling, and myocardial mechanical behavior in a population-based multiethnic cohort: the Multi-Ethnic Study of Atherosclerosis …

S Donekal, BA Venkatesh, YC Liu, CY Liu… - Circulation …, 2014 - Am Heart Assoc
Background—Tagged cardiac magnetic resonance provides detailed information on
regional myocardial function and mechanical behavior. T1 mapping by cardiac magnetic …

Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation …

K Debl, B Djavidani, S Buchner, C Lipke, W Nitz… - Heart, 2006 - heart.bmj.com
Objective: To compare the extent and distribution of focal fibrosis by gadolinium contrast-
enhanced magnetic resonance imaging (MRI; delayed hyperenhancement) in severe left …

[HTML][HTML] Rationale and design of the randomized, controlled early valve replacement guided by biomarkers of left ventricular decompensation in asymptomatic patients …

R Bing, RJ Everett, C Tuck, S Semple, S Lewis… - American Heart …, 2019 - Elsevier
Background The optimal timing of aortic valve replacement in asymptomatic patients with
aortic stenosis is uncertain. Replacement fibrosis, as assessed by midwall (nonischemic) …

Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of …

M Puls, BE Beuthner, R Topci… - European heart …, 2020 - academic.oup.com
Aims Myocardial fibrosis (MF) might represent a key player in pathophysiology of heart
failure in aortic stenosis (AS). We aimed to assess its impact on left ventricular (LV) …

[HTML][HTML] Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker …

CM de Ravenstein, C Bouzin, S Lazam, J Boulif… - Journal of …, 2015 - Elsevier
Abstract Background Gadolinium (Gd) Extracellular volume fraction (ECV) by
Cardiovascular Magnetic Resonance (CMR) has been proposed as a non-invasive method …

Markers of myocardial damage predict mortality in patients with aortic stenosis

S Kwak, RJ Everett, TA Treibel, S Yang… - Journal of the American …, 2021 - jacc.org
Background Cardiovascular magnetic resonance (CMR) is increasingly used for risk
stratification in aortic stenosis (AS). However, the relative prognostic power of CMR markers …

CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF

MYM Su, LY Lin, YHE Tseng, CC Chang, CK Wu… - JACC: Cardiovascular …, 2014 - jacc.org
Objectives: The purpose of this study was to investigate diffuse myocardial fibrosis in
patients with systolic heart failure (SHF) and in patients with heart failure with preserved …

Assessment of subclinical left ventricular dysfunction in aortic stenosis

JS Dahl, J Magne, PA Pellikka, E Donal… - JACC: Cardiovascular …, 2019 - jacc.org
Left ventricular (LV) systolic dysfunction is an adverse consequence of the pressure
overload of severe aortic stenosis (AS). The enlargement of the interstitial space with …

Association of longitudinal changes in left ventricular structure and function with myocardial fibrosis: the Multi-Ethnic Study of Atherosclerosis study

B Ambale Venkatesh, GJ Volpe, S Donekal… - …, 2014 - Am Heart Assoc
The association of longitudinal changes in left ventricular (LV) structure and function with
myocardial fibrosis is unclear. We relate temporal changes in body size–indexed LV mass …